|
|
Research and Markets: Epigenetic Targets in Drug Discovery - Everything a Drug Researcher Needs to Know about
|
Drug Interactions with New and Investigational Antiretrovirals: darunavir, etravirine, rilpivirine (TMC278), m
|
Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectro
|
NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck
|
Waters Corporation (WAT) Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other Hig
|
Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectro
|
Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectro
|
Ontario, Canada Investing in Science to Strengthen Economy Government Launches New Fund for Genomics Research
|
GlaxoSmithKline Accelerates Research with BioTrove's RapidFire Mass Spectrometry System at Two Key U.S. R&D Si
|
GlaxoSmithKline Accelerates Research with BioTrove's RapidFire Mass Spectrometry System at Two Key U.S. R&D S
|
Dyer & Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased Sequenom, Inc. Common Stock
|
Stanley Mandel & Iola and the Braun Law Group Announce the Filing of a Class Action Lawsuit Against Sequenom,
|
INVESTOR NOTICE: The Rosen Law Firm Announces Filing of Securities Class Action Against Sequenom, Inc. -- SQNM
|
Izard Nobel LLP Announces Class Action Lawsuit Against Sequenom, Inc
|
Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
|
Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Cla
|
Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Cla
|
AstraZeneca India gears to be ready with TB drug candidate for safety studies by 2010
|
Abraxis BioScience and the California NanoSystems Institute Announce Partnership for Collaborative Research in the Development of New Nanobiotechnologies
|
Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference
|
